# Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

> **NCT03331302** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Virginia** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Hyperpolarized Xenon-129 MRI (Experimental)
- **DRUG:** Radioactive Xenon-133 scintigraphy (Active Comparator)

## Key facts

- **NCT ID:** NCT03331302
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-09-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03331302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03331302, "Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03331302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*